In a landmark decision, Pakistan has approved its first-ever National Vaccine Policy, aimed at boosting local vaccine production and ensuring self-sufficiency. The policy was greenlit during a high-level meeting chaired by Prime Minister Shehbaz Sharif on Wednesday.
Key Features of the Policy
The new policy outlines a comprehensive framework to enhance the country's vaccine manufacturing capabilities. It focuses on technology transfer, research and development, and public-private partnerships to reduce reliance on imported vaccines.
Local Production Goals
Under the policy, Pakistan aims to produce 80% of its vaccine requirements locally within the next five years. This move is expected to save billions in foreign exchange and ensure a stable supply of essential vaccines.
Regulatory Reforms
The policy also introduces regulatory reforms to streamline approval processes for new vaccines and encourage investment in the pharmaceutical sector. A dedicated Vaccine Authority will be established to oversee implementation.
Health experts have welcomed the initiative, calling it a game-changer for public health. "This policy will not only protect our population from preventable diseases but also position Pakistan as a regional hub for vaccine production," said Dr. Faisal Sultan, a former health adviser.
Impact on Public Health
The policy emphasizes equitable access to vaccines, particularly for vulnerable populations. It includes provisions for cold chain infrastructure, training of healthcare workers, and community engagement to boost vaccination coverage.
Pakistan has faced challenges in vaccine procurement during the COVID-19 pandemic, highlighting the need for self-reliance. The new policy addresses these gaps by promoting indigenous production of vaccines for polio, measles, hepatitis, and other diseases.
The approval of the National Vaccine Policy marks a significant step towards strengthening Pakistan's health security and achieving universal health coverage.
